Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Vincristine manufacturers

Filters

None products found

vincristine

Injection, lyophilized 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, PICS, MHRA, WHO
Manufacturer #38657

The company is a pharmaceutical manufacturer engaged in the development, production and export of a range of pharmaceutical products across key therapeutic segments including oncology, critical care and lifesaving medicines, operating with certified manufacturing capabilities and global distribution networks to supply these pharmaceutical products to international healthcare markets.

Manufacturer usually replies in 7 days

vincristine

Vials 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10170
A pharmaceutical manufacturer providing export-oriented development and commercial supply of pharmaceutical products across a complete range of finished dosage forms, including tablets, capsules, softgels, injectables, ointments, dry syrups, and sachet presentations. The organisation positions itself as a licensing-and-supply partner with integrated manufacturing expertise and a growing international portfolio, and it reports holding multiple regulatory approvals from major global authorities (including MHRA, TGA, ANVISA and GCC regulators) alongside WHO-GMP compliance for its manufacturing operations, supporting consistent quality and reliability of pharmaceutical products for overseas partners.

Manufacturer usually replies in 29 days

vincristine

Injection 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Liposome inejction
Manufacturer #36255

Established in 2013, this manufacturer specializes in oncology, focusing on the research, manufacturing, and marketing of high-quality specialty formulations. As a CTD dossier owner and manufacturer, it holds GMP certifications from international regulatory authorities, including USFDA, MHRA, and PIC/S, ensuring compliance with stringent quality standards. The manufacturer operates a state-of-the-art facility in Hyderabad, India, designed to meet global regulatory requirements. As a CTD dossier owner and manufacturer, its products are distributed worldwide. With a commitment to innovation and quality, the manufacturer aims to provide the best options to oncologists and their patients.

Manufacturer usually replies in 31 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Vincristine is a chemotherapic medication used to treat a variety of cancers, including acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer. Suppliers market it in the form of an intravenous solution. The drug was developed and first introduced to the market in 1963 and initially marketed by supplier Eli Lilly. Since then, other manufacturing companies, such as Teva, Pfizer, and Gedeon Richter have joined the market with their vincristine formulations. As of now, the medication is available in both generic and trade name forms and the World Health Organization has included it in its list of Essential Medicines needed for a basic health system. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. 1ml unit of 1mg/ml vincristine solution costs approximately 8.00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.